Related Experiment Video

Updated: Jun 30, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK

Tasneem Pirani1, Anthony Wilson2, David Brealey3

  • 1Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.

British Journal of Anaesthesia
|March 23, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CAR-T therapyICUICU outcomeshaemato-oncologyimmune therapiesimmunocompromised patients

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

504
Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level08:09

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

844

Related Concept Videos